Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial ...

Last summer, Lilly started selling vials of the 2.5 mg and 5 mg doses of Zepbound online through its LillyDirect platform. Patients either need a prescription from their doctor or can get one ...

In February, Lilly cut prices for patients paying for single-dose Zepbound vials without insurance by $50 a month for 2.5 milligrams, a common starting dosage, and 5 milligrams. The charge is $349 ...

Novo Nordisk announced a direct-to-consumer program that allows patients to buy Wegovy out of pocket at a lower cost.

Novo Nordisk announced launching a direct-to-patient online pharmacy NovoCare, offering a more than half-price cut for its ...

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

Demand for Wegovy and Zepbound is booming, but supply issues and limited insurance coverage have curtailed access to the pricey medications.

Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. Read more about ...

Eli Lilly's drive to provide as many treatment options as possible for its weight-loss drug Zepbound has continued with the launch of new high-dose vials sold at a $150 discount to its auto ...

Given the optimism around its obesity candidate, we believe investors should stay invested in Viking Therapeutics.